Bivision

About:

Bivision is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT).

Website: http://www.bivisionpharma.com/

Top Investors: Gaorong Capital, Kaitai Capital, Yijing Capital, Huajin Capital, Tigermed

Description:

Biovision Pharma is a biomedical enterprise focusing on the research and development of targeted radiopharmaceuticals (TRT) integrated with visual diagnosis and treatment.

Total Funding Amount:

200M CNY

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2021-01-01

Contact Email:

info(AT)bivisionpharma.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-07-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai